Response to Julio Pascual regarding Kishore-Kumar et al. (Pain, 37 (1989) 223-227)
Max
Mitchell B
MB
Neurobiology and Anesthesiology Branch, National Institute of Dental Research, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892 U.S.A. Laboratory of Clinical Science, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892 U.S.A.
Kishore-Kumar
Ranganna
R
Lawlor
Brian A
BA
Murphy
Dennis L
DL
D000700:Analgesics / Q000627:therapeutic use*; D002065:Buspirone / Q000627:therapeutic use*; D006801:Humans; D010146:Pain / Q000188:drug therapy / Q000378:metabolism*; D010879:Piperazines / Q000627:therapeutic use*; D012701:Serotonin / Q000378:metabolism*
D000700:Analgesics; D010879:Piperazines; D012701:Serotonin; C015068:1-(3-chlorophenyl)piperazine; D002065:Buspirone